Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates ONC Bullish with a Setup Score of 0, net conviction 18, actionability 0. How the Setup Score works →
Total Setup Score
0
Directional Bias
Bullish
Net Conviction
18
Actionability
0 (in range)
Key signals behind this score
Fresh Trend Turn — 200wk turn 30w
80wk Uptrend — rising+above (sma 287 vs px 302)
200wk Uptrend — rising+above (sma 230 vs px 302)
Seasonal Tailwind — july med 16.8% (mag 2/3) · posClose 80.00% (rel 2/3) · n10 ×1 = 8
Founder-Led — founder/CEO led
About BeiGene, Ltd.
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVA… Read full Trend Edge analysis →
Founder-Led: Yes — John V. Oyler (Co-Founder, Chairman & Chief Executive Officer), Xiaodong Wang (Co-Founder, Chairman of the Scientific Advisory Board)
Key Metrics
Current Price
$302.83
Market Cap
$30.88B
Float
78.2M
Shares Outstanding
94.9M
P/E (Forward)
44.05
P/E (TTM)
67.49
Price/Sales (TTM)
5.38
vs. Analyst Target
+36.2% to analyst PT
Profit Margin
8.94%
Operating Margin (TTM)
16.51%
Revenue (TTM)
$5.74B
Earnings Growth (YoY)
16970.80%
Dividend Rate
None
Analyst Target Price
$412.38 (24 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$309M
-$1.62B
$238M
-$1.63B
2021
$1.18B
-$1.46B
$1.01B
-$1.39B
2022
$1.42B
-$2.00B
$1.13B
-$1.89B
2023
$2.46B
-$882M
$2.08B
-$738M
2024
$3.81B
-$645M
$3.22B
-$361M
2025
$5.34B
$287M
$4.67B
$617M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$1.32B
$94.3M
Sep 2025
$1.41B
$125M
Dec 2025
$1.50B
$66.5M
Mar 2026
$1.51B
$227M
Ownership & Float
Insider Ownership
17.3%
Institutional Ownership
33.0%
Short Float
1.2%
% of All Funds Holding
3.24%
Number of Funds Holding
266
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$288.87
Near-term / short-term trend
Weekly
40-Week SMA
$312.98
Medium-term trend
Weekly
80-Week SMA
$287.29
Cyclical trend (business cycle)
Weekly
200-Week SMA
$229.57
Secular trend (multi-year)
Monthly
10-Month SMA
$308.02
Near-term monthly trend
Monthly
20-Month SMA
$286.46
Medium-term monthly trend
Monthly
40-Month SMA
$236.37
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$245.00
support
1.02x
11 months ago
$221.00
support
1.49x
16 months ago
$183.00
support
1.08x
17 months ago
$165.00
support
1.39x
22 months ago
$145.00
support
1.10x
23 months ago
Historical Earnings Reactions (41 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.07%
-0.05%
43.90%
7.88%
-5.12%
1 Day
0.33%
-0.22%
41.46%
12.12%
-10.36%
1 Week
1.01%
1.79%
63.41%
15.33%
-16.06%
2 Weeks
0.02%
-0.71%
43.90%
31.98%
-31.47%
1 Month
0.06%
-1.28%
46.34%
32.84%
-25.85%
Next earnings: August 5, 2026 (26 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
8.4%
60.0%
10
Feb
2.8%
60.0%
10
Mar
-2.9%
36.4%
11
Apr
1.9%
36.4%
11
May
-2.0%
36.4%
11
Jun
1.0%
45.5%
11
Jul
14.7%
80.0%
10
Aug
3.4%
60.0%
10
Sep
7.0%
60.0%
10
Oct
-0.5%
50.0%
10
Nov
6.4%
60.0%
10
Dec
-4.4%
30.0%
10
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.06%
50.9%
489
Tuesday
0.35%
53.2%
539
Wednesday
0.26%
52.6%
536
Thursday
-0.04%
47.7%
528
Friday
0.11%
50.2%
526
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 33.0%
Insider Transactions — Smart Summary
Total insider ownership: 17.3%
Founder-led management: John V. Oyler (Co-Founder, Chairman & Chief Executive Officer), Xiaodong Wang (Co-Founder, Chairman of the Scientific Advisory Board)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for BeiGene, Ltd.
(ONC) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.